← Back to all trials
Not Yet Recruiting
NCT07096726
Boston Medical Center Ultrasound Decongestion Study in Heart Failure
Conditions: Congestive Heart Failure, Volume Overload
Sex: All
Ages: 18 Years – N/A
Healthy volunteers: No
Phase: NA
Enrollment: 200
Sponsor: Boston Medical Center
Location: Boston Medical Center Boston Massachusetts
Summary
The purpose of this study is to analyze the utility of a novel five-point ultrasound as a predictor of volume overload in diverse patients who are admitted with volume overload/congestive heart failure (CHF) exacerbation at Boston Medical Center (BMC), the largest safety-net hospital in New England. Current standard of care (SOC) involves the utilization of laboratory markers and physical exam, which is often inconsistent and equivocal. The investigators will assess will assess if ultrasound-assisted diuresis reduces recurrent episodes of volume overload/decompensated heart failure.
Eligibility Criteria
Inclusion Criteria:
* Patient with a primary diagnosis of acute on chronic decompensated heart failure who is admitted to inpatient or presents to the outpatient Boston Medical Center (BMC) Heart Failure Infusion clinic for decongestion treatment.
* Willing and able to receive short abdominal and thoracic ultrasounds throughout hospitalization
* Patients with right and/or left ventricular failure
Exclusion Criteria:
* Hemodynamic instability defined as systolic blood pressure \
Source: ClinicalTrials.gov (NCT07096726). StuddyBuddy aggregates publicly available trial information.